EGF and autosomal dominant polycystic kidney disease: Previous investigations reported that urinary EGF holds promise as a valuable biomarker that reflects disease activity across various kidney disorders, including lupus nephritis [32], diabetic kidney disease [33,34,35], IgA nephropathy [36,37], and autosomal dominant polycystic kidney disease [38].